François Montier

A non‐peptide NK₁‐receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically

Saliha Moussaoui, François Montier, A. Carruette et al. · British Journal of Pharmacology · 1993 · 64 citations · Full text

Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.

J. Pratz, S. Mondot, François Montier et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 46 citations

Antagonism of substance P and related peptides by RP 67580 and CP-96,345, at tachykinin NK1 receptor sites, in the rat urinary bladder

François Montier, A. Carruette, Saliha Moussaoui et al. · European Journal of Pharmacology · 1994 · 23 citations

Urology, Molecular Physiology, Signal Transduction +11

In vivo pharmacological properties of RPR100893, a novel non-peptide antagonist of the human NK1 receptor

Saliha Moussaoui, François Montier, A. Carruette et al. · Neuropeptides · 1994 · 18 citations

Molecular Pharmacology, Vivo Pharmacological Properties, G Protein-coupled Receptor +9

Increase in Plasma Renin Activity Evoked by Fenoldopam in Dogs is Directly Mediated by Dopamine1 Receptor Stimulation

François Montier, Philippe Katchadourian, J. Pratz et al. · Journal of Cardiovascular Pharmacology · 1989 · 16 citations

Hypertension, Pharmacotherapy, Experimental Pharmacology +22